Education
Evolving Treatment Options for the Treatment of HCC with Immunotherapy and LDT
Array
Activity Info
This activity addresses ongoing research on emerging immunotherapy agents and clinical trial data on the use of these agents in combination, succession, and sequentially with interventional liver directed therapy (LDT).
NO LONGER AVAILABLE FOR CREDIT. CME Information is available on the activity landing page.
